• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by ReShape Lifesciences Inc

    ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Participate in Investor and Industry Conferences in June
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Update
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 Diabetes
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    Tickers RSLS
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.